"FDA Requires Boxed Warning and Risk Mitigation Strategy for Metoclopramide-
Containing Drugs
The U.S. Food and Drug Administration announced today that manufacturers
of metoclopramide, a drug used to treat gastrointestinal disorders, must add a
boxed warning to their drug labels about the risk of its long-term or high-dose
use. Chronic use of metoclopramide has been linked to tardive dyskinesia,
which may include involuntary and repetitive movements of the body, even
after the drugs are no longer taken."
more: http://www.fda.gov/bbs/topics/NEWS/2009/NEW01963.html
linda
author "Baby Matters"
***********************************************
Archives: http://community.lsoft.com/archives/LACTNET.html
To reach list owners: [log in to unmask]
Mail all list management commands to: [log in to unmask]
COMMANDS:
1. To temporarily stop your subscription write in the body of an email: set lactnet nomail
2. To start it again: set lactnet mail
3. To unsubscribe: unsubscribe lactnet
4. To get a comprehensive list of rules and directions: get lactnet welcome